Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.545,76
0,53%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Acadia Pharmaceuticals Inc (ACAD) Acadia Pharmaceuticals Inc (ACAD) Notizie

Acadia Pharmaceuticals Inc

ACAD
14,87
-0,22 (-1,46%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202423:23EDGAR2Form 8-K - Current report
29/5/202422:55EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:54EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/5/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
15/5/202415:05BWAcadia Pharmaceuticals Announces Launch of Magnolia's Guide..
09/5/202422:58BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
08/5/202422:10EDGAR2Form 8-K - Current report
08/5/202422:05BWAcadia Pharmaceuticals Reports First Quarter 2024 Financial..
29/4/202422:16BWAcadia Pharmaceuticals is Proud to Announce the Winners of..
24/4/202422:05BWAcadia Pharmaceuticals to Announce First Quarter Financial..
22/4/202415:04BWAcadia Pharmaceuticals Announces Trofinetide New Drug..
19/4/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
17/4/202422:05BWAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide)..
02/4/202422:05BWAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive..
01/4/202422:05BWAcadia Pharmaceuticals to Participate in the 23rd Annual..
15/3/202421:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
13/3/202421:05BWAcadia Pharmaceuticals to Participate in the UBS Virtual CNS..
12/3/202412:21IHMARKETNEWSOracle Soars 13% With Exceptional Growth and Boosts Nvidia..
11/3/202421:05EDGAR2Form 8-K - Current report
11/3/202421:05BWAcadia Pharmaceuticals Announces Top-Line Results from Phase..
29/2/202415:05BWAcadia Pharmaceuticals to Participate in TD Cowen’s 44th..
28/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:16EDGAR2Form 8-K - Current report
27/2/202422:05BWAcadia Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14/2/202413:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202422:05BWAcadia Pharmaceuticals to Announce Fourth Quarter and Full..
08/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/1/202403:55EDGAR2Form 8-K - Current report
31/1/202402:48BWAcadia Announces Additions to Executive Team
26/1/202423:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 15,01 Min: 14,81 Max: 15,12
Chiusura: 15,09

La tua Cronologia

NASDAQ
ACAD
Acadia Pharmaceuticals
BITMOT
2773678
Btp Fx 2.95% Feb27 Eur
NASDAQ
SHPW
Shapeways
USOTC
ERRAF
Emera (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network